(Q27853009)

English

TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations

scientific article

In more languages

Statements

scholarly article

1 reference

13 November 2016

TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations (English)

1 reference

13 November 2016

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Xiaopeng Tian

1

0 references

Yang Xu

2

0 references

Jia Yin

3

0 references

Hong Tian

4

0 references

Suning Chen

5

0 references

Depei Wu

6

0 references

Aining Sun

7

0 references

publication date

July 2014

0 references

International Journal of Hematology

0 references

100

0 references

96-104

0 references

1

0 references

https://scigraph.springernature.com/pub.10.1007/s12185-014-1595-x

0 references

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Genetics of myeloid malignancies: pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Genetics of myeloid leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

New prognostic markers in acute myeloid leukemia: perspective from the clinic

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

The role of FLT3 in haematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

TET2 is essential for survival and hematopoietic stem cell homeostasis.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1595-X

21 January 2018

Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24859829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/24859829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24859829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-014-1595-X

0 references

Dimensions Publication ID

0 references

1 reference

13 November 2016

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853009&oldid=1521266472"